Inventor
O'SHEA CLODAGH
US15 patents
Patents
15 patentsUS9913866B2Mar 13, 2018
Selective cell targeting using adenovirus and chemical dimers
SALK INST FOR BIOLOGICAL STUDI25 citations91
US10738325B2Aug 11, 2020
Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
SALK INST FOR BIOLOGICAL STUDI10 citations82
US9217160B2Dec 22, 2015
Adenoviral assembly method
SALK INST FOR BIOLOGICAL STUDI13 citations82
US9187733B2Nov 17, 2015
Anti-cancer adenoviruses
SALK INST FOR BIOLOGICAL STUDI10 citations82
US12281324B2Apr 22, 2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics
SALK INST FOR BIOLOGICAL STUDI2 citations72
US11401529B2Aug 2, 2022
Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics
SALK INST FOR BIOLOGICAL STUDI3 citations71
US11130968B2Sep 28, 2021
High throughput assay for measuring adenovirus replication kinetics
SALK INST FOR BIOLOGICAL STUDI3 citations71
US10577589B2Mar 3, 2020
Adenoviral assembly method
SALK INST FOR BIOLOGICAL STUDI3 citations71
US11077156B2Aug 3, 2021
Oncolytic adenovirus compositions
SALK INST FOR BIOLOGICAL STUDI3 citations70
US11813337B2Nov 14, 2023
Tumor-targeting synthetic adenoviruses and uses thereof
SALK INST FOR BIOLOGICAL STUDI0 citations62
US11730781B2Aug 22, 2023
Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
SALK INST FOR BIOLOGICAL STUDI0 citations62
US12589128B2Mar 31, 2026
Oncolytic adenovirus compositions
SALK INST FOR BIOLOGICAL STUDI0 citations59
US12514887B2Jan 6, 2026
Oncolytic tumor viruses and methods of use
SALK INST FOR BIOLOGICAL STUDI0 citations59
US10821141B2Nov 3, 2020
HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancers
SALK INST FOR BIOLOGICAL STUDI1 citations58
US12365878B2Jul 22, 2025
Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4
SALK INST FOR BIOLOGICAL STUDI0 citations57